FDA Drug Application (203263) for DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) by SUN PHARMA GLOBAL

Back to FDA Applications sponsored by SUN PHARMA GLOBAL

Application Number203263
Product Number001
FormINJECTABLE, LIPOSOMAL;INJECTION
Dosage20MG/10ML (2MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Active IngredientDOXORUBICIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient DOXORUBICIN HYDROCHLORIDE5


Back to FDA Applications sponsored by SUN PHARMA GLOBAL